EdouardFortunet

Associé

Paris + 33.1.56.59.38.34

Contact

Partager

Edouard Fortunet co-dirige la pratique Brand Protection & Enforcement de Jones Day dans le monde.

Dans le domaine contentieux, il intervient sur des litiges stratégiques en matière de droits d'auteur, de marques, de dessins et modèles et de concurrence déloyale, pour des clients nationaux et internationaux et devant les juridictions françaises et de l’Union européenne. En complément de son activité judiciaire, Edouard Fortunet conseille les clients sur leurs stratégies globales de protection de leurs actifs immatériels (création, protection, développement et respect des droits de propriété intellectuelle).

Edouard Fortunet dispose également d’une solide expertise dans le domaine transactionnel. Il a assisté un grand nombre de sociétés sur les aspects propriété intellectuelle liés à leur introduction en bourse, ainsi que lors d’opérations complexes de fusion-acquisition françaises et internationales. Il gère au quotidien des projets multi-juridictionnels et travaille en étroite collaboration avec les clients pour concevoir, structurer et mettre en œuvre, au regard de leurs intérêts économiques, des partenariats technologiques et commerciaux à forts enjeux. Il exerce principalement dans les domaines de la tech, de l’énergie, des sciences de la vie, de l’entertainment et du retail.

Edouard Fortunet est membre de l'APRAM (Association des Praticiens du Droit des Marques et Modèles [membre du bureau] [Président de la Commission "PI dans l'Economie"]), de l'INTA (Association Internationale des Marques), de l'AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), et de l'AIDV (Association Internationale du Droit du Vin).

Expérience

  • Amolyt Pharma acquired by AstraZenecaJones Day advised Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, in its $1.05 billion acquisition by AstraZeneca.
  • Partech Partners leads €37 million Series B financing of CintooJones Day represented Partech Partners as lead investor in the €37 million Series B financing of Cintoo, the leading provider of cloud-based Reality Data management and collaboration solutions.
  • Silver Lake Waterman, Eurazeo, Partech Partners, Eight Roads, F-Prime, and Serena Capital participate in $54 million Series C financing of OdasevaJones Day advised Silver Lake Waterman, the lead new investor, and Eurazeo, a new investor, as well as historical investors Partech Partners, Eight Roads, F-Prime and Serena Capital in connection with the $54 million Series C financing of Odaseva, the leading enterprise data security platform for Salesforce, along with new investor Crescent Cove.
  • Société Générale sells Société Générale Equipment Finance's (SGEF) activitiesJones Day is advising Société Générale in the sale of the professional equipment financing businesses operated by Societe Generale Equipment Finance (SGEF) to Groupe BPCE.
  • Euroclear invests in IZNESJones Day advised Euroclear in its investment in IZNES, a pan-European funds marketplace based on blockchain technology.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • BNP Paribas, Bryan Garnier, and Natixis complete €141 million capital increase of CarbiosJones Day advised BNP Paribas, Bryan Garnier, and Natixis in connection with the €141 million capital increase with shareholders' preferential subscription rights of Carbios, a biotech company specialized in the development and industrialization of biological technologies used for plastic and textiles recycling.
  • Orano and XTC New Energy create two JVs dedicated to the production of batteries for electric vehiclesJones Day is advising Orano in the context of the setting-up of two joint-ventures dedicated to the production of critical materials for batteries for electric vehicles, together with Chinese group XTC New Energy.
  • Optium Capital leads Series A financing of BeFCJones Day advised Otium Capital in leading the €16 million Series A financing of BeFC, a French start-up company providing a sustainable paper-based biofuel cell and ecofriendly microelectronics.
  • Uniphore Technologies acquires HexagonJones Day advised Uniphore Technologies, a provider of conversational artificial intelligence and automation, in the acquisition of Hexagone, which fuses voice, visual, and text-based data to provide AI-derived insights to help better understand human behavior.
  • Électricité de Strasbourg forms JV with ErametJones Day advised Électricité de Strasbourg, an energy provider in Alsace (France), in the formation of a joint venture with Eramet, one of the leading French actors in the mining and metallurgy industries, to develop and use joint capabilities for the extraction, refining and production of lithium from geothermal resources, with a targeted annual volume of 10,000 tons of lithium corresponding to the volume necessary to produce c.250,000 batteries for electric vehicles per year).
  • Swile and Groupe BPCE to combine to create global leader in employee benefitsJones Day advised Swile, a worktech unicorn, in the acquisition of Bimpli, a subsidiary of Groupe BPCE and leader in employee services and benefits in France.
  • Ansys acquires automotive simulation channel partner DYNAmoreJones Day is representing Ansys, Inc. in the acquisition of the DYNAmore business (“DYNAmore”), a Stuttgart, Germany-headquartered company who has historically distributed Ansys’ LS-DYNA crash test simulation software to virtually all major European car manufacturers.
  • Eurobio Scientific acquires GenDxJones Day advised Eurobio Scientific SA in the acquisition and financing of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for €135 million (net of adjusted cash).
  • EDAP completes follow-on public offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on public offering of 3,066,667 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • Creadev and Temasek invest in InnovafeedJones Day advised Creadev SAS and Temasek, investors in the $250 million Series D financing of Innovafeed, a leader in the production of insects (Hermetia Illucens) for animal and plant nutrition.
  • Deezer merges with and into I2PO S.A.Jones Day advised Deezer S.A. in the context of the SPAC transaction whereby Deezer S.A. merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • Castor raises $23.5 million in Series A financingJones Day represented Castor SAS, data catalog platform, in its $23.5 million Series A financing round led by Blossom.
  • Simpson Manufacturing Company announces offer to acquire Etanco GroupJones Day advised Simpson Manufacturing Company, Inc. in the €725 million acquisition of the Etanco Group.
    •

    October 2024 Commentary

    French Supreme Court Sets New Boundary to Liability Toward Third Parties

    April 2024 Alert

    UK Court of Appeal Diverges From EU Trademark Law

    March 2024 Alert

    UK Supreme Court Rejects Amazon's Trademark Infringement Appeal

    February 2023 Alert

    Can EU Operators of Online Marketplaces be Held Liable for Trademark Infringement?

    January 2023 Commentary

    EU Anti-Counterfeit Regulation Does Not per se Allow Repackaging of Parallel Imported or Parallel Traded Pharmaceuticals

    May 2022 Commentary

    Trademark Revocation Actions for Non-Use: Who Bears the Burden?

    May 2022 Commentary

    NFTs: U.S., EU, and UK Key Trademark Considerations

    April 2022 Commentary

    NFTs: U.S., EU, and UK Key Copyright Considerations

    March 2022 Commentary

    Which AI Components Are Copyright Protectable and Which Are Not?

    May 2018 Commentary

    EU Consumer Rights Enforcement—Penalties Ahead
    Voir toutes les publications

    Autres publications

    • 2024
      Intellectual Property Rights in France Overview, Practical Law Country Q&A
    • 2024
      Intellectual Property Transactions in France Overview, Practical Law Country Q&A
    • 2024
      Terminating Licences of IP Rights (France) 2024
    • 2024
      Terminating Licenses of IP Rights QC Chart (France)
    • December 15 2020
      IP in business transactions: France overview (Thomson Reuters)
    • December 15, 2020
      Patents, trade marks, copyright and designs in France: overview
    • February 2020
      Participation to the drafting of 2 Chapters of Thomson Reuters IP in Business Transactions Global Guide

    • 30 mars 2017
      Les rendez-vous de la propriété intellectuelle - 1er volet : Gestion des créations de salariés
    • 17 novembre 2016
      Atelier AFJE "Négocier un contrat de cession d'actions pro-vendeur"

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.